What does it take to develop new antibiotics and ensure they reach the patients who need them most?
In 2025, GARDP reached important milestones in the fight against antimicrobial resistance (AMR),...
What does it take to develop new antibiotics and ensure they reach the patients who need them most?
In 2025, GARDP reached important milestones in the fight against antimicrobial resistance (AMR),...
Peptide Dangers: The Risks Behind This Health Trend #TheIdexPodcast
Health podcasts and influencers praise peptides as health boosts but they lack clinical studies and aren't licensed medicine. Counterfeit drugs are dangerous, you never know what you're injecting.
...
Learn how the European Medicines Agency's PRIME (PRIority MEdicines) scheme helps accelerate the development of promising medicines for patients with unmet medical needs.
In this video, Kevin Cunn...
Learn how the European Medicines Agency's PRIME (PRIority MEdicines) scheme helps accelerate the development of promising medicines for patients with unmet medical needs.
In this video, Kevin Cunn...
Corinne de Vries, EMA lead on medicines in pregnancy and breastfeeding, explains how better safety data can be generated at every stage of a medicine’s lifecycle.
Up to 90% of women who are pregnant or breastfeeding use medicines, yet for many of these treatments, reliable safety data remains limited. Why does this gap exist—and how can it be addressed?
In ...
Tocando a Real - Drogas Sintéticas: O mercado ilegal de drogas mudou e muitas ameaças agora vêm direto dos tubos de ensaio. São os entorpecentes sintetizados em laboratório. Neste episódio, o apres...
Assistência Farmacêutica na pandemia: evidências do Projeto PAF-Covid para o SUS
Lista de presença:
https://docs.google.com/forms/d/e/1FAIpQLSfR_1hRT47FhyXWPx5uSVubKBbAPK776_GA6vlUzle4sv75uA/viewform
www.fiocruzbrasilia.fiocruz.br
facebook.com/fiocruzbrasilia
instagram.com/fi...
Curious why the ever so popular parcha suddenly vanished?
Well, he didn’t really vanish, just got an…upgrade!
#NextGenHealth - Built for Billions
From clinical trials to real world evidence. How is data shaping the future of medicines?
Discover how EMA uses data to guide safer, better decisions.
In this episode of Inside EMA, we explore ho...
Boletim Ciência aproxima a ciência do público. O convidado desta edição é o líder do Núcleo de Estudos Clínicos em Imunologia e Vacinas do Hospital Israelita Albert Einstein, Henrique Fonseca.
Pro...
Have you ever wondered how the European Pharmacopoeia came into being? How did we arrive at a single pharmaceutical reference work now used so widely across Europe and beyond? What is the story tha...
In this video, we describe the role of clinical trials in the development and approval of medicines.
Learn how researchers test thousands of substances, how clinical trials are carefully designed...
In this video, we describe the role of clinical trials in the development and approval of medicines.
Learn how researchers test thousands of substances, how clinical trials are carefully designed...
In this video, we describe the role of clinical trials in the development and approval of medicines.
Learn how researchers test thousands of substances, how clinical trials are carefully designed...
Since June 2025, MSF has been using PANAF, a WHO‑prequalified antivenom, and conducting a study to assess its effectiveness in treating snakebite envenoming. The findings of this study will be shar...
Who are the people behind the approval of medicines in the EU?
Meet the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), the scientific committee responsible for e...
ما وراء التشخيص: نحو الالتفات إلى مرضى الثلاسيميا
في سوريا، لا تزال الثلاسيميا تشكّل تحديًا بارزًا في مجال الصحة العامة، إذ يُقدَّر أن نحو 5% من السكان هم من حاملي سمة الثلاسيميا.
#أطباء_بلا_حدود #الثلاسيميا #سوريا